US Map / Utah
State UT

Clinical Trials in Utah

Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 187 actively recruiting studies with Utah sites out of 187 registered in total. The busiest research areas in Utah are Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer. Leading sponsors running trials in the state include University of Utah, AstraZeneca, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (41), Phase 2 (58), Phase 3 (49), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
187
Recruiting Now
187
← Back to US Map
Top Conditions in Utah
Multiple Myeloma (4)Heart Failure (4)Non-small Cell Lung Cancer (3)Ulcerative Colitis (3)Breast Cancer (3)Stroke (3)Prostate Cancer (3)Acute Myeloid Leukemia (2)Hidradenitis Suppurativa (HS) (2)Neuroblastoma (2)Non-Small Cell Lung Cancer (2)Ovarian Cancer (2)

Frequently Asked Questions — Clinical Trials in Utah

How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 187 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 187. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Utah

NCT07450547 Phase 2
Recruiting
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Condition
Exocrine Pancreatic Insufficiency (EPI)
Enrollment
113 pts
Location
United States
Sponsor
Anagram Therapeutics, Inc.
View Trial →
NCT07645287 Phase 2
Recruiting
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologica...
Condition
HIV-1-infection
Enrollment
175 pts
Location
United States, Australia, Canada
Sponsor
Gilead Sciences
View Trial →
NCT06887452 N/A
Recruiting
Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
Condition
Gout
Enrollment
310 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06934343 N/A
Recruiting
Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell ...
Condition
Non-small Cell Lung Cancer
Enrollment
144,400 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT07226661 Phase 2
Recruiting
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
Condition
Major Depressive Disorder (MDD)
Enrollment
230 pts
Location
United States
Sponsor
Supernus Pharmaceuticals, Inc.
View Trial →
NCT07406633 Phase 2
Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIS...
Condition
GIST - Gastrointestinal Stromal Tumor
Enrollment
46 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
View Trial →
NCT07360080 N/A
Recruiting
Long-Term Outcomes of Teplizumab in Routine Clinical Care
Condition
Type 1 Diabetes
Enrollment
1,000 pts
Location
United States, Germany, Israel
Sponsor
Sanofi
View Trial →
NCT05183854 Phase 2
Recruiting
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chroni...
Condition
Chronic Lymphocytic Leukemia
Enrollment
61 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT05338697 N/A
Recruiting
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future...
Condition
Stroke
Enrollment
657 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT06625073 Phase 4
Recruiting
Randomized Trial of SGLT2i in Heart Transplant Recipients
Condition
Heart Transplant
Enrollment
200 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
View Trial →
NCT07605416 Phase 2
Recruiting
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, Th...
Condition
Plasma Cell Leukemia
Enrollment
74 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07207707 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Ad...
Condition
Solid Tumor Malignancies
Enrollment
78 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
View Trial →
NCT06860594 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Th...
Condition
Astrocytoma, IDH-Mutant, Grade 2
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT06850805 Phase 3
Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adole...
Condition
Chronic Rhinosinusitis Without Nasal Polyps
Enrollment
84 pts
Location
United States
Sponsor
Optinose US Inc.
View Trial →
NCT05244486 N/A
Recruiting
Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Pos...
Condition
Erectile Dysfunction Following Radical Prostatectomy
Enrollment
200 pts
Location
United States
Sponsor
Charitable Union for the Resea
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
View Trial →
NCT07780656 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Com...
Condition
Pulmonary Disease, Chronic Obstructive
Enrollment
624 pts
Location
United States, Argentina
Sponsor
GlaxoSmithKline
View Trial →
NCT06883305 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participa...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
990 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyr...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
100 pts
Location
United States, France, Italy
Sponsor
Nurix Therapeutics, Inc.
View Trial →
NCT05490472 Phase 1, Phase 2
Recruiting
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Condition
Solid Tumors
Enrollment
102 pts
Location
United States, China
Sponsor
Jacobio Pharmaceuticals Co., L
View Trial →
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
Page 4 of 8 — 187 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology